Delta-9-tetrahydrocannabinol: comments on antiemetic trials.
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001682:Biological Availability; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D013759:Dronabinol / Q000378:metabolism / Q000627:therapeutic use*; D005059:Euphoria; D006801:Humans; D007408:Intestinal Absorption; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy*; D009369:Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents; D013759:Dronabinol